Mainolfi Nello — SEC Form 4 filings
SEC reporting owner CIK 1821189. 17 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2024-03-04 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 22 legs across 9 filings — 410,000 shares, $36,345,394 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 100,000 shares @ $89.17 ($8,917,000) in Kymera Therapeutics, Inc., filed 2025-12-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Executive Officer, Director | 17 | — | 22 legs · 410,000 sh · $36,345,394 | 32 |
Form 4 filings — Mainolfi Nello
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 50,000 @ $2.08 · Sale (S): 50,000 @ $119 · Option exercise (M): 45,559 (derivative) @ $0 · Option exercise (M): 4,441 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 80,000 @ $2.08 · Sale (S): 1,883 @ $112.80 · Sale (S): 6,626 @ $113.98 · Sale (S): 24,105 @ $114.96 · Sale (S): 44,050 @ $115.69 · Sale (S): 3,336 @ $116.56 · +1 more | EDGAR |
| 2026-04-29 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 30,000 @ $2.08 · Sale (S): 17,005 @ $80.74 · Sale (S): 12,059 @ $81.70 · Sale (S): 936 @ $82.45 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 30,000 @ $2.08 · Sale (S): 19,764 @ $89.78 · Sale (S): 5,434 @ $90.39 · Sale (S): 3,293 @ $91.76 · Sale (S): 1,501 @ $92.81 · Sale (S): 8 @ $93.49 · +1 more | EDGAR |
| 2026-01-06 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 3,118 @ $32.07 · Option exercise (M): 3,118 (derivative) @ $0 | EDGAR |
| 2025-12-31 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 30,000 @ $2.08 · Sale (S): 23,986 @ $77.95 · Sale (S): 6,014 @ $78.52 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 2,595 @ $38.53 · Option exercise (M): 2,595 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 100,000 @ $2.08 · Sale (S): 100,000 @ $89.17 · Option exercise (M): 100,000 (derivative) @ $0 | EDGAR |
| 2025-10-29 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 30,000 @ $2.08 · Sale (S): 1,862 @ $59.72 · Sale (S): 24,511 @ $61.02 · Sale (S): 3,627 @ $61.46 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-09-16 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 30,000 @ $2.08 · Sale (S): 30,000 @ $49 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 30,000 @ $2.08 · Sale (S): 30,000 @ $49 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 365,000 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 10,000 @ $2.08 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 18,773 @ $5.33 · Option exercise (M): 18,773 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 14,413 @ $2.08 · Option exercise (M): 14,413 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 530,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821189 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →